主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SEER
#3273
Seer, Inc. Class A Common Stock
1.7
2
-16.50%
版块:
基础:
利润货币:
日范围
年范围
日变化
-16.50%
每月变动
-9.47%
6个月变化
-16.50%
年变化
-20.74%
前一天收盘价
2.0
6
Open
1.7
2
Bid
Ask
Low
1.7
2
High
1.7
2
交易量
15
市场
股票
医疗保健
SEER
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2021
2022
2023
2024
Total assets
539.14 M
487.93 M
436.27 M
366.6 M
Total liabilities
36.22 M
40.94 M
39.37 M
39.03 M
Total equity
502.92 M
446.99 M
396.9 M
327.57 M
Total liabilities & shareholders' equities
539.14 M
487.93 M
436.27 M
366.6 M
Total debt
—
—
—
—
Net debt
—
—
—
—
Seer Inc - Class A
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
新闻
Seer, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SEER) 2026-02-27
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer 2025年第四季度业绩:装机量激增67%,营收未达预期
Seer Q4 2025 slides: installed base surges 67%, revenue misses mark
Seer Q4 每股收益 超出预期, 营收 低于预期
Seer earnings beat by $0.02, revenue fell short of estimates
Seer将在美国HUPO会议上展示蛋白质组学技术
Seer to showcase proteomics technology at US HUPO conference
Mass spectrometry study validates protein-gene associations for drug discovery
Seer, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SEER) 2025-11-26
Seer公司在CG医疗科技论坛:蛋白质组学创新引领潮流
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way